Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New On...(1; the American Dietetic Association ...)

Date:7/8/2008

1; the American Dietetic Association – has come out with a stance that advocates food biotechnology and reinforces its safety,” explains Chin. “There are many other health professional organizations, such as the American Medical Association, then international organizations like the World Health Organization, which also support the safety of food biotechnology; and not only because of the benefit from the safety perspective, but also because of the nutritional benefits and its ability to potentially feed hungry people in the world.”

This new video can be viewed, downloaded or embedded into another Web site from the Conversations about Plant Biotechnology Web site. In addition, visitors to the Web site can view videos with farmers about the need for GM crops in Burkina Faso, as well as with global experts who want greater access to GM technology in developing countries to benefit subsistence farming.

The Conversations about Plant Biotechnology is designed to give a voice and a face to the farmers and families who grow GM crops and the experts who research and study the benefits of biotechnology
'/>"/>

Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved

2 GOOD

Page: 1 2 3 4
Related biology technology :

1. Awareness of Genzymes Renvela(R) (Sevelamer Carbonate) is High, Although Uptake of this New Phosphate Binding Agent has Been Slower than Nephrologists and Renal Dietitians Initially Expected
2. BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
3. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
4. KV Pharmaceutical Company Comments on Legal Development in Its Branded Pharmaceutical Business
5. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
6. American Oriental Bioengineering Comments on Earthquake
7. InfuSystem Holdings Provides Business Update and Comments on Fourth Quarter 2007 Financial Results
8. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
9. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
10. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
11. New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus (MRSA)